Kyle Lefkoff, Director at MIRAGEN THERAPEUTICS, INC. (MGEN), sold 24,392 shares at $14.70 ($378K) on 2017-03-08, disclosed to the SEC on 2017-03-08.
Open-market sale of $378k MGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.71 | 9,392 | $148K | 39.0% |
| 2 | $15.71 | 9,392 | $148K | 39.0% |
| 3 | $16.24 | 608 | $10K | 2.6% |
| 4 | $14.70 | 5,000 | $74K | 19.4% |
| Total | $15.52 avg | 24,392 | $378K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |